No Data
No Data
Express News | MannKind Corp: Expects to Ship Product for Cipla Ltd. by End of 2025
CDSCO Approves Afrezza (Insulin Human) Inhalation Powder in India
MannKind Corporation's (NASDAQ:MNKD) Institutional Investors Lost 3.9% Last Week but Have Benefitted From Longer-term Gains
Insider Sale: Director at $MNKD (MNKD) Sells 67,536 Shares
Tudor Pickering Holt Downgrades MannKind to Hold From Buy, Adjusts Price Target to $5.50 From $7
Oppenheimer Maintains MannKind(MNKD.US) With Buy Rating, Maintains Target Price $12
loading...
No Data
I Am 102927471 :